Intellectual Property India Publishes Patent Application for 'Heterocyclic Compound For Inducing Degradation Of Mutant Kras Protein' Filed by Astellas Pharma Inc.

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202547016301 A) filed by Astellas Pharma Inc., Tokyo, on Feb. 25, for 'heterocyclic compound for inducing degradation of mutant kras protein.'

Inventor(s) include Morikawa, Takahiro; Imada, Sunao; Hamaguchi, Hisao; Okumura, Mitsuaki; Imaizumi, Tomoyoshi; Koganemaru, Yohei; Honjo, Eriko; Fujiwara, Yuta; Kawaminami, Eiji; Yoshinari, Tomohiro; Ishioka, Hiroki; Kuramoto, Kazuyuki; and Nishizono, Yoshihiro.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "Provided is a compound useful as an active ingredient in a pharmaceutical composition for treatin...